Trial Profile
A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary) ; Ketamine; Zolpidem
- Indications Obesity
- Focus Pharmacodynamics
- Sponsors Arena Pharmaceuticals; Eisai Inc
- 20 Mar 2010 Results have been presented at the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 10 Dec 2009 Positive data has been reported at the 48th Annual Meeting of the American College of Neuropsychopharmacology, according to an Arena Pharmaceuticals media release.